How much does Yintarui (Linperlisib Tablets) Cost& price without insurance in China?
Yintarui® is the commercial brand name of Linperlisib Tablets, an orally selective PI3Kδ inhibitor developed by YL-Pharma. It blocks the PI3Kδ signaling pathway in B lymphocytes, thereby inhibiting tumor cell proliferation and survival.
Main Indications
Treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior systemic therapies.
Common Side Effects
Common mild adverse reactions: Neutropenia, thrombocytopenia, anemia, diarrhea, and fatigue.
Laboratory abnormalities: Elevated liver enzymes, increased triglycerides, and decreased lymphocyte counts.
Severe but uncommon risks: Severe infections, pneumonitis, hepatotoxicity, and severe cutaneous adverse reactions.
Approval Status in China
Yintarui® (Linperlisib Tablets, 20mg) was officially approved for marketing in China in 2024. It is currently a prescription anti-tumor drug included in China’s National Medical Insurance List.
Buy Yintarui (Linperlisib Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
